In March, the Food and Drug Administration (FDA) approved semaglutide (brand name: Wegovy) for just that purpose after a study published last November showed that the medication lowers certain peoples risk for those events by as much as 20%
Many people taking it have seen dramatic results
5,6 We did not evaluate the impact of discontinuing semaglutide or the potential side effects reported in previous trials, which include an elevated risk of developing thyroid cancer, gallbladder-related disorders, or gastrointestinal disorders
Storage and Shipping Considerations Lyophilized peptides are temperature-sensitive, so transit affects the material before you open it
protein naturally stimulates satiety hormones, working in tandem with the medication
People who are pregnant or plan to become pregnant in the next two months should not take semaglutide